Site-specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site

Author:

Guo Kaibo1,Li Lu2345,Feng Yuqian1,Sun Leitao16,Zhang Kai6,Liu Shan7,Shao Yi Feng8,Ruan Shanming16

Affiliation:

1. The First School of Clinical Medicine; Zhejiang Chinese Medical University; Hangzhou China

2. Pharmaceutical Informatics Institute; College of Pharmaceutical Sciences, Zhejiang University; Hangzhou China

3. State Key Laboratory of Component-Based Chinese Medicine; Innovation Center in Zhejiang University; Hangzhou China

4. Department of Obstetrics and Gynaecology; Sir Run Run Shaw Hospital, Zhejiang University School of Medicine; Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province; Hangzhou China

5. Department of Obstetrics and Gynaecology; Li Ka Shing Institute of Health Sciences; School of Biomedical Sciences; Sichuan University-Chinese University of Hong Kong Joint Reproductive Medicine Laboratory, The Chinese University of Hong Kong; Shatin Hong Kong

6. Department of Medical Oncology; The First Affiliated Hospital of Zhejiang Chinese Medical University; Hangzhou China

7. Department of Clinical Evaluation Center; The First Affiliated Hospital of Zhejiang Chinese Medical University; Hangzhou China

8. The First Clinical Medical College; Zhejiang Chinese Medical University; Hangzhou China

Publisher

Wiley

Subject

Pharmacology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3